Complex vasoactivity of liraglutide. Contribution of three gasotransmitters

Background: Incretine hormone glucagon-like peptide-1 (GLP-1) causes dose-dependent relaxation of the thoracic aorta of rats and other arteries via nitric oxide (NO), cAMP and ATP-sensitive potassium channels, however, through a mechanism not thoroughly described. Hereby we aimed to determine the me...

Full description

Bibliographic Details
Main Authors: Eszter Sélley, Gergő A. Molnár, Szilárd Kun, István András Szijártó, Boglárka Laczy, Tibor Kovács, Ferenc Fülöp, István Wittmann
Format: Article
Language:English
Published: Atlantis Press 2015-05-01
Series:Artery Research
Subjects:
Online Access:https://www.atlantis-press.com/article/125925198/view
id doaj-cf9a4c336674405097da15e549e504b0
record_format Article
spelling doaj-cf9a4c336674405097da15e549e504b02020-11-25T01:30:45ZengAtlantis PressArtery Research 1876-44012015-05-011110.1016/j.artres.2015.04.001Complex vasoactivity of liraglutide. Contribution of three gasotransmittersEszter SélleyGergő A. MolnárSzilárd KunIstván András SzijártóBoglárka LaczyTibor KovácsFerenc FülöpIstván WittmannBackground: Incretine hormone glucagon-like peptide-1 (GLP-1) causes dose-dependent relaxation of the thoracic aorta of rats and other arteries via nitric oxide (NO), cAMP and ATP-sensitive potassium channels, however, through a mechanism not thoroughly described. Hereby we aimed to determine the mediators involved in the vasoactive effect of liraglutide. Methods: Isolated rat aortic rings and segments of the femoral artery were mounted in a wire myograph to study the vasoactive effect of liraglutide. Vessels were preincubated either with inhibitors of gasotransmitter-, prostaglandin- or reactive oxygen species-formation, or with inhibitors of protein kinases, potassium channels or the Na+/Ca2+-exchanger. Results: According to our findings, liraglutide activates endothelial cells and vascular smooth muscle cells leading to the production of NO, carbon monoxide, hydrogen sulphide, superoxide anion, and hydrogen peroxide. Increased production of such relaxing factors promotes the activation of protein kinase– A and –G, resulting in the activation of potassium channels (ATP-sensitive-, voltage-gated-, large-conductance-calcium activated), which profoundly contributes to the activation of the Na+/Ca2+-exchanger, thereby leading to calcium efflux and smooth muscle relaxation and vasorelaxation. Conclusions: We reveal the contribution of all gasotransmitters in the vasorelaxation induced by liraglutide. We provide ex vivo evidence that liraglutide is capable of causing vasodilatation in the central and peripherial vessels, thereby supporting the clinical observation that it lowers blood pressure.https://www.atlantis-press.com/article/125925198/viewAortic ringsCentral (aortic) vasodilatationGLP-1Liraglutide
collection DOAJ
language English
format Article
sources DOAJ
author Eszter Sélley
Gergő A. Molnár
Szilárd Kun
István András Szijártó
Boglárka Laczy
Tibor Kovács
Ferenc Fülöp
István Wittmann
spellingShingle Eszter Sélley
Gergő A. Molnár
Szilárd Kun
István András Szijártó
Boglárka Laczy
Tibor Kovács
Ferenc Fülöp
István Wittmann
Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
Artery Research
Aortic rings
Central (aortic) vasodilatation
GLP-1
Liraglutide
author_facet Eszter Sélley
Gergő A. Molnár
Szilárd Kun
István András Szijártó
Boglárka Laczy
Tibor Kovács
Ferenc Fülöp
István Wittmann
author_sort Eszter Sélley
title Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
title_short Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
title_full Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
title_fullStr Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
title_full_unstemmed Complex vasoactivity of liraglutide. Contribution of three gasotransmitters
title_sort complex vasoactivity of liraglutide. contribution of three gasotransmitters
publisher Atlantis Press
series Artery Research
issn 1876-4401
publishDate 2015-05-01
description Background: Incretine hormone glucagon-like peptide-1 (GLP-1) causes dose-dependent relaxation of the thoracic aorta of rats and other arteries via nitric oxide (NO), cAMP and ATP-sensitive potassium channels, however, through a mechanism not thoroughly described. Hereby we aimed to determine the mediators involved in the vasoactive effect of liraglutide. Methods: Isolated rat aortic rings and segments of the femoral artery were mounted in a wire myograph to study the vasoactive effect of liraglutide. Vessels were preincubated either with inhibitors of gasotransmitter-, prostaglandin- or reactive oxygen species-formation, or with inhibitors of protein kinases, potassium channels or the Na+/Ca2+-exchanger. Results: According to our findings, liraglutide activates endothelial cells and vascular smooth muscle cells leading to the production of NO, carbon monoxide, hydrogen sulphide, superoxide anion, and hydrogen peroxide. Increased production of such relaxing factors promotes the activation of protein kinase– A and –G, resulting in the activation of potassium channels (ATP-sensitive-, voltage-gated-, large-conductance-calcium activated), which profoundly contributes to the activation of the Na+/Ca2+-exchanger, thereby leading to calcium efflux and smooth muscle relaxation and vasorelaxation. Conclusions: We reveal the contribution of all gasotransmitters in the vasorelaxation induced by liraglutide. We provide ex vivo evidence that liraglutide is capable of causing vasodilatation in the central and peripherial vessels, thereby supporting the clinical observation that it lowers blood pressure.
topic Aortic rings
Central (aortic) vasodilatation
GLP-1
Liraglutide
url https://www.atlantis-press.com/article/125925198/view
work_keys_str_mv AT eszterselley complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT gergoamolnar complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT szilardkun complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT istvanandrasszijarto complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT boglarkalaczy complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT tiborkovacs complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT ferencfulop complexvasoactivityofliraglutidecontributionofthreegasotransmitters
AT istvanwittmann complexvasoactivityofliraglutidecontributionofthreegasotransmitters
_version_ 1725090141916102656